ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.198,49
0,72%
S&P 500
5.494,02
0,13%
Dow Jones
38.917,54
0,21%
Euro vs US Dollar
1,07299
-0,16%
Bitcoin
64.873,84
-0,14%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. LianBio (LIAN)

  7. LianBio (LIAN) News

LIAN

LianBio (LIAN)

LianBio
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:LIAN
DatumZeitQuelleÜberschriftSymbolFirma
11/03/202412h51Edgar (US Regulatory)Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:LIANLianBio
28/02/202413h00GlobeNewswire Inc.LianBio Announces Voluntarily Delisting from NasdaqNASDAQ:LIANLianBio
20/02/202422h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LIANLianBio
13/02/202413h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LIANLianBio
13/02/202413h00GlobeNewswire Inc.LianBio Announces Completion of Strategic ReviewNASDAQ:LIANLianBio
08/01/202412h13Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LIANLianBio
29/12/202313h56Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LIANLianBio
26/12/202322h10Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LIANLianBio
26/12/202322h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LIANLianBio
26/12/202320h40AllPennyStocks.comBiotech Finds Success Following Holiday WeekendNASDAQ:LIANLianBio
26/12/202308h00GlobeNewswire Inc.LianBio Enters into Agreement Assigning its Rights for NBTXR3 in China and Other Asian MarketsNASDAQ:LIANLianBio
20/12/202314h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LIANLianBio
20/12/202314h00GlobeNewswire Inc.LianBio Announces Departure of Chief Financial OfficerNASDAQ:LIANLianBio
19/12/202322h26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LIANLianBio
19/12/202322h05GlobeNewswire Inc.LianBio Announces Departure of Chief Executive OfficerNASDAQ:LIANLianBio
06/12/202322h23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LIANLianBio
06/12/202322h05GlobeNewswire Inc.LianBio’s Board of Directors Unanimously Determines not to Pursue Unsolicited Proposal from Concentra BiosciencesNASDAQ:LIANLianBio
01/12/202322h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LIANLianBio
01/12/202322h05GlobeNewswire Inc.LianBio Confirms Receipt of Unsolicited Proposal from Concentra BiosciencesNASDAQ:LIANLianBio
13/11/202322h28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LIANLianBio
13/11/202322h17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LIANLianBio
13/11/202322h05GlobeNewswire Inc.LianBio Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:LIANLianBio
30/10/202321h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LIANLianBio
30/10/202321h05GlobeNewswire Inc.LianBio Announces Topline Results from Phase 3 LIBRA Trial of TP-03 in Chinese Patients with Demodex BlepharitisNASDAQ:LIANLianBio
25/10/202322h05GlobeNewswire Inc.LianBio Announces Presentation of Data from Phase 2a Study of Infigratinib in Patients with Gastric Cancer at ESMO Congress 2023NASDAQ:LIANLianBio
24/10/202316h25AllPennyStocks.comBiotech Shares Soar PremarketNASDAQ:LIANLianBio
24/10/202315h22Dow Jones NewsLianBio Shares Soar Premarket on Strategic Review, End of Bristol PactNASDAQ:LIANLianBio
24/10/202312h59GlobeNewswire Inc.LianBio Enters into Agreement with Bristol Myers Squibb for Mavacamten in China and Other Asian MarketsNASDAQ:LIANLianBio
28/08/202322h05GlobeNewswire Inc.LianBio Announces Results from Phase 3 EXPLORER-CN Trial of Mavacamten Presented at the European Society of Cardiology Congress and Simultaneous Publication in JAMA CardiologyNASDAQ:LIANLianBio
14/08/202322h21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LIANLianBio
 Showing the most relevant articles for your search:NASDAQ:LIAN

Kürzlich von Ihnen besucht

AMEX
XLF
Financial Select Sector
AMEX
XLE
Energy Select Sector SPDR
TG
ALV
Allianz
PM
XAUUSD
Gold vs US Dollar
COIN
BTCUSD
Bitcoin
NYSE
DIS
Walt Disney
USOTC
BASFY
BASF (QX)
TG
LHA
Deutsche Lufthansa
NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
SILVER
SILVER
TG
RHM
Rheinmetall
COIN
ETHUSD
Ethereum
TG
MBG
MercedesBenz
FX
EURGBP
Euro vs Sterling
DBI
DAX
DAX
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten